Janelle Smolen, in Moorhead, MN - Specialist

Janelle Smolen, is a Specialist based in Moorhead, Minnesota. Janelle Smolen is licensed to practice in Minnesota (license number ) and her current practice location is 891 Belsly Blvd, Moorhead, Minnesota. She can be reached at her office (for appointments etc.) via phone at (218) 287-4338.

NPI number for Janelle Smolen is 1003211855 and her current mailing address is 891 Belsly Blvd, Moorhead, Minnesota. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1003211855.

Contact Information

	Janelle Smolen,
	891 Belsly Blvd, Moorhead, MN 56560-5055
	(218) 287-4338
	Not Available

Healthcare Provider's Profile

Full Name	Janelle Smolen
Gender	Female
Speciality	Specialist
Location	891 Belsly Blvd, Moorhead, Minnesota
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1003211855
Provider Enumeration Date: 10/22/2014
Last Update Date: 02/13/2017

Medical Identifiers

Medical identifiers for Janelle Smolen such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1003211855	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YM0800X	Counselor - Mental Health	(* (Not Available))	Secondary
174400000X	Specialist	(Minnesota)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Janelle Smolen is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Janelle Smolen, 891 Belsly Blvd, Moorhead, MN 56560-5055 Ph: (218) 287-4338	Janelle Smolen, 891 Belsly Blvd, Moorhead, MN 56560-5055 Ph: (218) 287-4338

News Archive

Study validates NT-proBNP as strong indicator for cardiovascular risk in arthritis patients

The role of N-terminal pro-B-type natriuretic peptide (NT-proBNP, a protein thought to be a regulator of cardiovascular function) as a robust, non-invasive predictor of cardiovascular (CV) risk in patients with arthritis taking cyclooxygenase inhibitors has been reinforced by the results of a multinational study presented today at EULAR 2010, the Annual Congress of the European League Against Rheumatism in Rome, Italy.

Doctors in Northern Ireland welcome HPV vaccination programme

Doctors in Northern Ireland have welcomed the Chief Medical Officer's announcement today, Wednesday 3 September 2008, to offer vaccination against the Human Papillomavirus (HPV) to all 12-13 year old girls in Northern Ireland. HPV is the virus which can lead to the development of cancer, in particular cervical cancer.

Self-referred medical imaging contributes to medical cost escalation

Physicians who have a financial interest in imaging equipment are more likely to refer their patients for potentially unnecessary imaging exams, according to a study presented today at the annual meeting of the Radiological Society of North America.

MicroStockProfit.com releases investment report on ANX

MicroStockProfit.com announces an investment report featuring ADVENTRX Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

Collaborative home-based palliative care for heart failure successful in UK

A collaborative home-based palliative care service for patients with advanced congestive heart failure could increase their chances of dying in their place of choice, show UK study results.

Janelle Smolen, - Counselor in Moorhead, MN